Tessera
Folgen

Daniel Batlle, MD

@daniel-batlle.bsky.social

Nephrologist at Northwestern University. Phyciam scientist with diverse research interests, from Acid-Base to ACE2. Proud grandfather. Soccer, go FC Barcelona!

52 Posts863 Follower362 Folgt
Daniel Batlle, MD@daniel-batlle.bsky.social · 2mo ago

Thanks to JASN @asnpublications.bsky.social for publishing our paper. Hopefully, this work will help define metabolic acidosis in CKD better by including data on estimated arterial pH and PCO2. Link: doi.org/10.1681/asn.... @feinberg.northwestern.edu @nu-nephrology.bsky.social

ASN Publications@asnpublications.bsky.social · 2mo ago

Research letter in #ASNJASN highlights the need for a comprehensive evaluation of acid-base status in CKD, advocating for integrating blood pH and PCO2 data, along with venous-to-arterial conversion formulas for enhanced clinical phenotyping. https://twp.ai/9OXm43 Daniel Batlle, MD

Daniel Batlle, MD@daniel-batlle.bsky.social · 5mo ago

Pleased to announce that my App is now available for free in both the Apple App Store and Google Play Store! You can find it under the name “Venous to Arterial Blood Gas”

Daniel Batlle, MD@daniel-batlle.bsky.social · 6mo ago

Thank you @asnpublications.bsky.social for posting our paper on the transformation of venous to arterial blood gas. To facilitate calculations, I developed an App “Venous to Arterial Blood Gas” available for free (apps.apple.com/us/app/venou...) @nu-nephrology.bsky.social @feinberg.northwestern.edu

Daniel Batlle, MD@daniel-batlle.bsky.social · 6mo ago

Thank you for posting our recent paper in Cell, a multicenter effort led by @rose-hill.bsky.social and @ardemp.bskyverified.social @nu-nephrology.bsky.social @nuintmed.bsky.social

Northwestern Feinberg School of Medicine@feinberg.northwestern.edu · 6mo ago

Scientists have discovered cellular mechanisms that regulate #renin production, an essential enzyme in the #kidney, findings that could improve our understanding of #kidney function and chronic #KidneyDisease, per @cp-cell.bsky.social. spr.ly/63321hdsov

Daniel Batlle, MD@daniel-batlle.bsky.social · 6mo ago

Thank you @asnpublications.bsky.social for posting our paper on the transformation of venous to arterial blood gas. To facilitate calculations, I developed an App “Venous to Arterial Blood Gas” available for free (apps.apple.com/us/app/venou...) @nu-nephrology.bsky.social @feinberg.northwestern.edu

Venous to Arterial Blood Gas App - App Store

Download Venous to Arterial Blood Gas by Daniel Batlle on the App Store. See screenshots, ratings and reviews, user tips, and more apps like Venous to Arterial…

apps.apple.com

ASN Publications@asnpublications.bsky.social · 6mo ago

This #ASNKidney360 study explored the relationship between arterial and venous blood gas parameters to develop formulas for estimating arterial values from venous samples. Read more: kidney.pub/KID1113

Barack Obama@barackobama.bsky.social · 6mo ago

The killing of Alex Pretti is a heartbreaking tragedy. It should also be a wake-up call to every American, regardless of party, that many of our core values as a nation are increasingly under assault.

Bild
Daniel Batlle, MD@daniel-batlle.bsky.social · 9mo ago

Good paper! Please also see our editorial in @kidneyint.bsky.social alerting to a possible new syndrome with features distinct but also overlapping with renal tubular acidosis. Link: doi.org/10.1016/j.ki... @nu-nephrology.bsky.social @nufeinbergmed.bsky.social

Redirecting

doi.org

Juan Carlos Q Vélez, MD@juancarlosqvelez.bsky.social · 9mo ago

Gain-of-function mutation of H+ATPase (gene ATP6V0A4) linked to renal tubular ALKALOSIS. dm5migu4zj3pb.cloudfront.net/manuscripts/...

Swapnil Hiremath 🍁🇨🇦@hswapnil.medsky.social · last yr.

~ 7% hyperkalemia with Finerenone in the 'real world' from the nonrandomized FINEREAL study via @nephtimes.bsky.social and #NKFClinicals www.docwirenews.com/post/interim... this is despite 43% flozination - so our prediction was prescient pubmed.ncbi.nlm.nih.gov/34400243/ #NephSky

Interim US Results From the FINE-REAL Study | Docwire News

At SCM25, researchers presented results of an interim analysis of the FINE-REAL study of finerenone among patients with chronic kidney disease (CKD) and type 2 diabetes.

docwirenews.com